 .png)
.png)
Report Library
View More
Datamonitor Healthcare Oncology Dis...
April 16, 2021
Datamonitor Healthcare Respiratory ...
April 15, 2021
Datamonitor Healthcare I&I Disease ...
April 15, 2021
Datamonitor Healthcare I&I Disease ...
April 14, 2021
Datamonitor Healthcare I&I Disease ...
April 14, 2021
Datamonitor Healthcare Oncology Dis...
April 8, 2021
Datamonitor Healthcare Infectious D...
April 7, 2021
Datamonitor Healthcare CNS Disease ...
March 31, 2021
Datamonitor Healthcare CV&Met Disea...
March 31, 2021
Datamonitor Healthcare CV&Met Disea...
March 31, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 4/15/21 | CellTrans | Donislecel for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/14/21 | GlaxoSmithKline (GSK) | Feladilimab for Head and Neck Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/13/21 | CellTrans | Donislecel for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/13/21 | Rigel Pharmaceuticals (RIGL) | Tavalisse for COVID-19 Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/13/21 | Gilead Sciences (GILD) | Trodelvy for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/16/21 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Filing (Europe) |
| 04/17/21 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 04/18/21 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 04/19/21 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
